Direct Meds GLP-1 vs Hims: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

52 providers verified independently·Independent researchHow we rank →

Direct Meds GLP-1 and Hims are tied at 7.9/10. Hims is more affordable at $199/mo vs $297/mo. Choose Direct Meds GLP-1 for users wanting simple, all-inclusive pricing without insuranc. Choose Hims for men who want a well-known publicly-traded brand and fda-appr.

A side-by-side look at Direct Meds GLP-1 and Hims to help you decide. We compare them on:

  • Starting price per month
  • Our overall score, out of 10
  • Medication type, brand-name or compounded
  • Whether they accept insurance
  • Who each one is best for

Direct Meds GLP-1

#10 of 52
7.9/10

Straightforward compounded GLP-1 program with transparent all-inclusive pricing and no hidden fees.

Visit Direct Meds GLP-1

Hims

#9 of 52
7.9/10

The household name in men's telehealth, publicly traded as Hims & Hers Health (NYSE: HIMS). In 2026 Hims added FDA-approved brand-name Wegovy (injection and pill) and Ozempic through a direct Novo Nordisk partnership, alongside their existing compounded semaglutide program. Brand recognition and product breadth are real strengths. The trade-off: Hims' verified Trustpilot rating is 3.0 stars across 8,286 reviews (May 2026), significantly below smaller competitors like Henry Meds (4.5) or Eden Health (4.5). The 1-star pool is 28%, the highest 1-star rate in our table, clustered around subscription/billing complaints.

Visit Hims
FeatureDirect Meds GLP-1Hims
Our Score7.9/107.9/10
Starting Price$297/mo$199/mo
Medication TypeCompoundedBoth
Insurance AcceptedNoNo
Best ForUsers wanting simple, all-inclusive pricing without insuranceMen who want a well-known publicly-traded brand and FDA-approved Wegovy through the 2026 Novo Nordisk partnership, but should know going in that Hims' customer-experience signal is weaker than smaller competitors
Ranking#10#9
Get startedVisit Direct Meds GLP-1Visit Hims

Pros & Cons Compared

Direct Meds GLP-1

Pros

  • +True all-inclusive pricing, $280/mo covers medication, consultations, shipping, and pharmacy fees with no add-ons
  • +Clear dose-based pricing published on their site, no surprise cost increases when titrating up
  • +Fast pharmacy fulfillment: most orders ship within 48 hours of provider approval
  • +Responsive customer support with live chat available during business hours

Cons

  • Compounded medications only, no brand-name Wegovy, Zepbound, or Ozempic on the menu
  • The $280/mo flat rate sits above Henry Meds ($199) and TrimRx ($149); Direct Meds' own sublingual drops at $179 are the budget path if the premium stings

Hims

Pros

  • +Publicly traded company (NYSE: HIMS), SEC-filed financials, regulatory accountability that private competitors don't have.
  • +2026 Novo Nordisk partnership, FDA-approved Wegovy injection, Wegovy pill, and Ozempic now available directly through Hims. Real brand-name access from a single platform.
  • +$199/mo all-inclusive for compounded semaglutide, including consultations and shipping.
  • +Polished app and web experience, among the best user interfaces in men's telehealth.
  • +8,286 verified Trustpilot reviews is the second-largest review volume in our table (after Henry's 12,461), significant real-world adoption.

Cons

  • Trustpilot rating is 3.0 stars / 8,286 reviews (May 2026), significantly below Henry Meds (4.5), Eden Health (4.5), Yucca Health (4.6), MEDVi (4.4). The lowest customer-experience signal of any major brand we track.
  • 28% of Trustpilot reviews are 1-star, the highest 1-star rate in our table. Top complaint themes: subscription handling, unexpected charges, customer service responsiveness.
  • Hims reviews span ALL their products (ED, hair loss, mental health, weight loss), not just GLP-1. But the rating still applies because most users don't separate experiences by product.
  • 'Hims Oral Kit' is NOT a GLP-1, it's a non-GLP-1 metabolic combination (metformin + bupropion + topiramate + B12 + naltrexone). Easy to confuse with their compounded semaglutide. Read the product page carefully before signing up.
  • Brand Wegovy at $599/mo is not competitive with LillyDirect/NovoCare cash prices or with Hers ($149/mo for the same product via the same Novo partnership).
  • Generic high-volume support, large patient base means less personalized attention than smaller competitors.

Our Verdict

Direct Meds GLP-1 and Hims are closely matched with identical scores of 7.9/10. If budget is your priority, Hims starts at $199/mo compared to Direct Meds GLP-1's $297/mo. Hims offers both brand-name and compounded medications, giving you more flexibility. Choose Direct Meds GLP-1 if you want: users wanting simple, all-inclusive pricing without insurance. Choose Hims if you want: men who want a well-known publicly-traded brand and fda-approved wegovy through the 2026 novo nordisk partnership, but should know going in that hims' customer-experience signal is weaker than smaller competitors.

Still undecided? Editor's Featured Pick

Yucca Health

$146/mo · 7.7/10 · Compounded

If neither Direct Meds GLP-1 nor Hims feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is Yucca Health. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $146/mo that stays the same at every dose.

Try Direct Meds GLP-1

Starting at $297/mo

Visit Direct Meds GLP-1

Try Hims

Starting at $199/mo

Visit Hims

Related comparisons

Other matchups readers comparing Direct Meds GLP-1 or Hims tend to look at next.

Not sure which one is right for you?

Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.

Featured Partners

Four affiliate partners we feature, we may earn a commission.

Yucca Health

7.7/10
$146/mo·Compounded

TrimRx

7.8/10
$149/mo·Compounded

Gala

7.2/10
$149/mo·Brand & Compounded

SkinnyRx

7.3/10
$199/mo·Compounded

Affiliate links, we earn a commission at no extra cost to you. These are featured partners, prioritized by our affiliate economics, not an editorial "best" ranking. The objective ranking (by methodology score) and full methodology are at glp1picks.com/best.